| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Levchin Max R | Chief Executive Officer, Director, 10%+ Owner | C/O AFFIRM HOLDINGS, INC., 650 CALIFORNIA STREET, SAN FRANCISCO | /s/ Josh Samples, Attorney-in-Fact | 2025-09-24 | 0001539853 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AFRM | Class A Common Stock | Options Exercise | $31.9M | +652K | $49.00 | 652K | Sep 22, 2025 | Direct | F1 | |
| transaction | AFRM | Class A Common Stock | Sale | -$16.4M | -186K | -28.51% | $88.46 | 466K | Sep 22, 2025 | Direct | F1, F2 |
| transaction | AFRM | Class A Common Stock | Sale | -$23.2M | -260K | -55.74% | $89.23 | 206K | Sep 22, 2025 | Direct | F1, F3 |
| transaction | AFRM | Class A Common Stock | Sale | -$18.2M | -203K | -98.26% | $90.02 | 3.59K | Sep 22, 2025 | Direct | F1, F4 |
| transaction | AFRM | Class A Common Stock | Sale | -$327K | -3.59K | -100% | $90.98 | 0 | Sep 22, 2025 | Direct | F1, F5 |
| holding | AFRM | Class A Common Stock | 735K | Sep 22, 2025 | By Levchin 2012 Irrevocable Trust | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AFRM | Performance Based Stock Options | Options Exercise | $0 | -652K | -5.51% | $0.00 | 11.2M | Sep 22, 2025 | Class A Common Stock | 652K | $49.00 | Direct | F1, F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2025. |
| F2 | Represents the weighted average sale price of the shares sold from $87.75 to $88.7493 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | Represents the weighted average sale price of the shares sold from $88.75 to $89.745 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | Represents the weighted average sale price of the shares sold from $89.75 to $90.71 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | Represents the weighted average sale price of the shares sold from $90.825 to $91.02 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | As joint settlors of the Levchin 2012 Irrevocable Trust, the Reporting Person and his spouse jointly have the right to acquire the shares held by the trust but do not have voting or investment power over such shares. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| F7 | The Reporting Person was granted a multi-year performance-based stock option (the "Value Creation Award") on January 12, 2021. The Value Creation Award is divided into ten tranches which the Reporting Person may earn by satisfying a performance condition within a five-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer. The earned tranches of the Value Creation Award becomes vested and exercisable upon the satisfaction of a time condition. Any portion of the Value Creation Award that has not been earned by the fifth anniversary of the grant date will be forfeited. As of September 22, 2025, the Reporting Person has earned 4,000,000 stock options, all of which have vested. |